SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Ziopharm Oncology Inc – ‘10-Q/A’ for 6/30/12 – ‘XML’

On:  Tuesday, 8/28/12, at 4:07pm ET   ·   For:  6/30/12   ·   Accession #:  1144204-12-48414   ·   File #:  1-33038

Previous ‘10-Q’:  ‘10-Q’ on 8/2/12 for 6/30/12   ·   Next:  ‘10-Q’ on 11/8/12 for 9/30/12   ·   Latest:  ‘10-Q’ on 11/14/23 for 9/30/23

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/28/12  Ziopharm Oncology Inc             10-Q/A      6/30/12   50:3.1M                                   Toppan Merrill/FA

Amendment to Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q/A      Amendment to Quarterly Report                       HTML     29K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     20K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     20K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     18K 
32: R1          Document and Entity Information                     HTML     37K 
23: R2          Balance Sheets                                      HTML    112K 
30: R3          Balance Sheets (Parenthetical)                      HTML     39K 
34: R4          Statements Of Operations                            HTML     67K 
46: R5          Statement Of Stockholders' Equity                   HTML     66K 
24: R6          Statement Of Stockholders' Equity (Parenthetical)   HTML     18K 
29: R7          Statements of Cash Flows                            HTML    142K 
21: R8          Business                                            HTML     26K 
15: R9          Summary of Significant Accounting Policies          HTML     19K 
47: R10         Collaborations and Alliances                        HTML     21K 
36: R11         Fair Value Measurements                             HTML     38K 
35: R12         Net Loss per Share                                  HTML     23K 
40: R13         Related Party Transactions                          HTML     22K 
41: R14         Commitments and Contingencies                       HTML     53K 
39: R15         Warrants                                            HTML     52K 
42: R16         Common Stock                                        HTML     19K 
31: R17         Stock-Based Compensation                            HTML     48K 
33: R18         Fair Value Measurements (Tables)                    HTML     27K 
38: R19         Net Loss per Share (Tables)                         HTML     22K 
50: R20         Warrants (Tables)                                   HTML     42K 
44: R21         Stock-Based Compensation (Tables)                   HTML     52K 
26: R22         Business - Additional Information (Detail)          HTML     23K 
37: R23         Collaborations and Alliances - Additional           HTML     24K 
                Information (Detail)                                             
28: R24         Assets and Liabilities Measured at Fair Value on    HTML     26K 
                Recurring Basis (Detail)                                         
13: R25         Potential Dilutive Shares Excluded from             HTML     26K 
                Computation of Diluted Net Loss Per Share (Detail)               
45: R26         Related Party Transactions - Additional             HTML     28K 
                Information (Detail)                                             
48: R27         Commitments and Contingencies - Additional          HTML    121K 
                Information (Detail)                                             
18: R28         Number of Warrants Outstanding (Detail)             HTML     21K 
17: R29         Warrants - Additional Information (Detail)          HTML     74K 
19: R30         Assumptions Used In Binomial Valuation Model and    HTML     25K 
                Black-Scholes Valuation Model (Detail)                           
20: R31         Warrant Exercise (Detail)                           HTML     32K 
22: R32         Common Stock - Additional Information (Detail)      HTML     34K 
11: R33         Stock-Based Compensation Expense on All Employee    HTML     23K 
                and Non-Employee Awards (Detail)                                 
43: R34         Stock-Based Compensation - Additional Information   HTML     31K 
                (Detail)                                                         
25: R35         Fair Value of Stock Options Assumptions Using       HTML     34K 
                Black-Scholes Option Valuation Model (Detail)                    
27: R36         Stock Option Activity Under Stock Option Plan       HTML     83K 
                (Detail)                                                         
14: R37         Summary of Unvested Restricted Stock (Detail)       HTML     46K 
49: XML         IDEA XML File -- Filing Summary                      XML     74K 
16: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS    392K 
 5: EX-101.INS  XBRL Instance -- ziop-20120630                       XML    731K 
 7: EX-101.CAL  XBRL Calculations -- ziop-20120630_cal               XML    109K 
 8: EX-101.DEF  XBRL Definitions -- ziop-20120630_def                XML    650K 
 9: EX-101.LAB  XBRL Labels -- ziop-20120630_lab                     XML    966K 
10: EX-101.PRE  XBRL Presentations -- ziop-20120630_pre              XML    726K 
 6: EX-101.SCH  XBRL Schema -- ziop-20120630                         XSD    147K 
12: ZIP         XBRL Zipped Folder -- 0001144204-12-048414-xbrl      Zip    101K

‘XML’   —   IDEA XML File — Filing Summary

This Document is an IDEA XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<FilingSummary xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
<Version> 2.4.0.6 </Version>
<ProcessingTime/>
<ReportFormat> Html </ReportFormat>
<ContextCount> 161 </ContextCount>
<ElementCount> 203 </ElementCount>
<EntityCount> 1 </EntityCount>
<FootnotesReported> false </FootnotesReported>
<SegmentCount> 68 </SegmentCount>
<ScenarioCount> 0 </ScenarioCount>
<TuplesReported> false </TuplesReported>
<UnitCount> 7 </UnitCount>
<MyReports>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R1.htm </HtmlFileName>
<LongName> 101 - Document - Document and Entity Information </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ziopharm.com/taxonomy/role/DocumentDocumentandEntityInformation </Role>
<ShortName> Document and Entity Information </ShortName>
</Report>
<Report>
<IsDefault> true </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R2.htm </HtmlFileName>
<LongName> 103 - Statement - Balance Sheets </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ziopharm.com/taxonomy/role/StatementOfFinancialPositionClassified </Role>
<ShortName> Balance Sheets </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R3.htm </HtmlFileName>
<LongName> 104 - Statement - Balance Sheets (Parenthetical) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ziopharm.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical </Role>
<ShortName> Balance Sheets (Parenthetical) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R4.htm </HtmlFileName>
<LongName> 105 - Statement - Statements Of Operations </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ziopharm.com/taxonomy/role/StatementOfIncomeAlternative </Role>
<ShortName> Statements Of Operations </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R5.htm </HtmlFileName>
<LongName> 106 - Statement - Statement Of Stockholders' Equity </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ziopharm.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome </Role>
<ShortName> Statement Of Stockholders' Equity </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R6.htm </HtmlFileName>
<LongName> 107 - Statement - Statement Of Stockholders' Equity (Parenthetical) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ziopharm.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncomeParenthetical </Role>
<ShortName> Statement Of Stockholders' Equity (Parenthetical) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R7.htm </HtmlFileName>
<LongName> 108 - Statement - Statements of Cash Flows </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ziopharm.com/taxonomy/role/StatementOfCashFlowsIndirect </Role>
<ShortName> Statements of Cash Flows </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R8.htm </HtmlFileName>
<LongName> 109 - Disclosure - Business </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ziopharm.com/taxonomy/role/NotesToFinancialStatementsBusinessDescriptionAndBasisOfPresentationTextBlock </Role>
<ShortName> Business </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R9.htm </HtmlFileName>
<LongName> 110 - Disclosure - Summary of Significant Accounting Policies </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ziopharm.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock </Role>
<ShortName> Summary of Significant Accounting Policies </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R10.htm </HtmlFileName>
<LongName> 111 - Disclosure - Collaborations and Alliances </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ziopharm.com/taxonomy/role/NotesToFinancialStatementsCollaborativeArrangementDisclosureTextBlock </Role>
<ShortName> Collaborations and Alliances </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R11.htm </HtmlFileName>
<LongName> 112 - Disclosure - Fair Value Measurements </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ziopharm.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlock </Role>
<ShortName> Fair Value Measurements </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R12.htm </HtmlFileName>
<LongName> 113 - Disclosure - Net Loss per Share </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ziopharm.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlock </Role>
<ShortName> Net Loss per Share </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R13.htm </HtmlFileName>
<LongName> 114 - Disclosure - Related Party Transactions </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ziopharm.com/taxonomy/role/NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlock </Role>
<ShortName> Related Party Transactions </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R14.htm </HtmlFileName>
<LongName> 115 - Disclosure - Commitments and Contingencies </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ziopharm.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock </Role>
<ShortName> Commitments and Contingencies </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R15.htm </HtmlFileName>
<LongName> 116 - Disclosure - Warrants </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ziopharm.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock </Role>
<ShortName> Warrants </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R16.htm </HtmlFileName>
<LongName> 117 - Disclosure - Common Stock </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ziopharm.com/taxonomy/role/NotesToFinancialStatementsCommonStockDisclosureTextBlock </Role>
<ShortName> Common Stock </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R17.htm </HtmlFileName>
<LongName> 118 - Disclosure - Stock-Based Compensation </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ziopharm.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock </Role>
<ShortName> Stock-Based Compensation </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R18.htm </HtmlFileName>
<LongName> 119 - Disclosure - Fair Value Measurements (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ziopharm.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlockTables </Role>
<ShortName> Fair Value Measurements (Tables) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R19.htm </HtmlFileName>
<LongName> 120 - Disclosure - Net Loss per Share (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ziopharm.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlockTables </Role>
<ShortName> Net Loss per Share (Tables) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R20.htm </HtmlFileName>
<LongName> 121 - Disclosure - Warrants (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ziopharm.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlockTables </Role>
<ShortName> Warrants (Tables) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R21.htm </HtmlFileName>
<LongName> 122 - Disclosure - Stock-Based Compensation (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ziopharm.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlockTables </Role>
<ShortName> Stock-Based Compensation (Tables) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R22.htm </HtmlFileName>
<LongName> 123 - Disclosure - Business - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ziopharm.com/taxonomy/role/DisclosureBusinessAdditionalInformation </Role>
<ShortName> Business - Additional Information (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R23.htm </HtmlFileName>
<LongName> 124 - Disclosure - Collaborations and Alliances - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ziopharm.com/taxonomy/role/DisclosureCollaborationsAndAlliancesAdditionalInformation </Role>
<ShortName> Collaborations and Alliances - Additional Information (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R24.htm </HtmlFileName>
<LongName> 125 - Disclosure - Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ziopharm.com/taxonomy/role/DisclosureAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasis </Role>
<ShortName> Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R25.htm </HtmlFileName>
<LongName> 126 - Disclosure - Potential Dilutive Shares Excluded from Computation of Diluted Net Loss Per Share (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ziopharm.com/taxonomy/role/DisclosurePotentialDilutiveSharesExcludedFromComputationOfDilutedNetLossPerShare </Role>
<ShortName> Potential Dilutive Shares Excluded from Computation of Diluted Net Loss Per Share (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R26.htm </HtmlFileName>
<LongName> 127 - Disclosure - Related Party Transactions - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ziopharm.com/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformation </Role>
<ShortName> Related Party Transactions - Additional Information (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R27.htm </HtmlFileName>
<LongName> 128 - Disclosure - Commitments and Contingencies - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ziopharm.com/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformation </Role>
<ShortName> Commitments and Contingencies - Additional Information (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R28.htm </HtmlFileName>
<LongName> 129 - Disclosure - Number of Warrants Outstanding (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ziopharm.com/taxonomy/role/DisclosureNumberOfWarrantsOutstanding </Role>
<ShortName> Number of Warrants Outstanding (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R29.htm </HtmlFileName>
<LongName> 130 - Disclosure - Warrants - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ziopharm.com/taxonomy/role/DisclosureWarrantsAdditionalInformation </Role>
<ShortName> Warrants - Additional Information (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R30.htm </HtmlFileName>
<LongName> 131 - Disclosure - Assumptions Used In Binomial Valuation Model and Black-Scholes Valuation Model (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ziopharm.com/taxonomy/role/DisclosureAssumptionsUsedInBinomialValuationModelAndBlackScholesValuationModel </Role>
<ShortName> Assumptions Used In Binomial Valuation Model and Black-Scholes Valuation Model (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R31.htm </HtmlFileName>
<LongName> 132 - Disclosure - Warrant Exercise (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ziopharm.com/taxonomy/role/DisclosureWarrantExercise </Role>
<ShortName> Warrant Exercise (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R32.htm </HtmlFileName>
<LongName> 133 - Disclosure - Common Stock - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ziopharm.com/taxonomy/role/DisclosureCommonStockAdditionalInformation </Role>
<ShortName> Common Stock - Additional Information (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R33.htm </HtmlFileName>
<LongName> 134 - Disclosure - Stock-Based Compensation Expense on All Employee and Non-Employee Awards (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ziopharm.com/taxonomy/role/DisclosureStockBasedCompensationExpenseOnAllEmployeeAndNonEmployeeAwards </Role>
<ShortName> Stock-Based Compensation Expense on All Employee and Non-Employee Awards (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R34.htm </HtmlFileName>
<LongName> 135 - Disclosure - Stock-Based Compensation - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ziopharm.com/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformation </Role>
<ShortName> Stock-Based Compensation - Additional Information (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R35.htm </HtmlFileName>
<LongName> 136 - Disclosure - Fair Value of Stock Options Assumptions Using Black-Scholes Option Valuation Model (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ziopharm.com/taxonomy/role/DisclosureFairValueOfStockOptionsAssumptionsUsingBlackScholesOptionValuationModel </Role>
<ShortName> Fair Value of Stock Options Assumptions Using Black-Scholes Option Valuation Model (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R36.htm </HtmlFileName>
<LongName> 137 - Disclosure - Stock Option Activity Under Stock Option Plan (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ziopharm.com/taxonomy/role/DisclosureStockOptionActivityUnderStockOptionPlan </Role>
<ShortName> Stock Option Activity Under Stock Option Plan (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R37.htm </HtmlFileName>
<LongName> 138 - Disclosure - Summary of Unvested Restricted Stock (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ziopharm.com/taxonomy/role/DisclosureSummaryOfUnvestedRestrictedStock </Role>
<ShortName> Summary of Unvested Restricted Stock (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<LongName> All Reports </LongName>
<ReportType> Book </ReportType>
<ShortName> All Reports </ShortName>
</Report>
</MyReports>
<Logs>
<Log type="Info"> Element us-gaap_OtherNonoperatingIncomeExpense had a mix of decimals attribute values: -5 -3. </Log>
<Log type="Info"> Element us-gaap_PrepaidExpenseAndOtherAssetsCurrent had a mix of decimals attribute values: -5 -3. </Log>
<Log type="Info"> Element us-gaap_SaleOfStockPricePerShare had a mix of decimals attribute values: 2 3. </Log>
<Log type="Info"> Element ziop_AssetAcquiredOtherThanThroughBusinessCombinationCashPaid had a mix of decimals attribute values: -5 -3. </Log>
<Log type="Info"> Element ziop_ClassOfWarrantOrRightFairValueAssumptionExpectedLife had a mix of decimals attribute values: 0 2. </Log>
<Log type="Info"> Element ziop_MilestonePaymentsMaximumAmount had a mix of decimals attribute values: -5 0. </Log>
<Log type="Info"> 'Monetary' elements on report '127 - Disclosure - Related Party Transactions - Additional Information (Detail)' had a mix of different decimal attribute values. </Log>
<Log type="Info"> 'Monetary' elements on report '128 - Disclosure - Commitments and Contingencies - Additional Information (Detail)' had a mix of different decimal attribute values. </Log>
<Log type="Info"> 'Monetary' elements on report '130 - Disclosure - Warrants - Additional Information (Detail)' had a mix of different decimal attribute values. </Log>
<Log type="Info"> Process Flow-Through: 103 - Statement - Balance Sheets </Log>
<Log type="Info"> Process Flow-Through: Removing column 'Jun. 30, 2011' </Log>
<Log type="Info"> Process Flow-Through: Removing column 'Dec. 31, 2010' </Log>
<Log type="Info"> Process Flow-Through: 104 - Statement - Balance Sheets (Parenthetical) </Log>
<Log type="Info"> Process Flow-Through: 105 - Statement - Statements Of Operations </Log>
<Log type="Info"> Process Flow-Through: 107 - Statement - Statement Of Stockholders' Equity (Parenthetical) </Log>
<Log type="Info"> Process Flow-Through: 108 - Statement - Statements of Cash Flows </Log>
</Logs>
<InputFiles>
<File> ziop-20120630.xml </File>
<File> ziop-20120630.xsd </File>
<File> ziop-20120630_cal.xml </File>
<File> ziop-20120630_def.xml </File>
<File> ziop-20120630_lab.xml </File>
<File> ziop-20120630_pre.xml </File>
</InputFiles>
<SupplementalFiles/>
<BaseTaxonomies/>
<HasPresentationLinkbase> true </HasPresentationLinkbase>
<HasCalculationLinkbase> true </HasCalculationLinkbase>
</FilingSummary>

↑Top
Filing Submission 0001144204-12-048414   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Fri., May 10, 10:21:10.1pm ET